• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION MAVERICK; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION MAVERICK; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS Back to Search Results
Model Number 7590
Medical Device Problem Codes Material Rupture (1546); Failure to Advance (2524); Difficult to Advance (2920)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 07/12/2023
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that balloon rupture occurred.The 95% stenosed target lesion was located in the severely tortuous and severely calcified left anterior descending artery.A 2.00mm x 20mm maverick balloon catheter was advanced for dilatation.However, during third inflation at 6 atmospheres, the balloon ruptured.The procedure was completed with another 2.00mm x 20mm maverick balloon catheter.There were no patient complications reported and the patient condition was good.
 
Additional Manufacturer Narrative
Device evaluated by mfr: returned product consisted of a maverick 2mr balloon catheter.The device was visually and microscopically examined.There was contrast and blood in the inflation lumen and the balloon.The balloon was loosely folded.There was a pinhole in the balloon located 1mm distal form the proximal end of the markerband.Product analysis confirmed the reported event, as the device was found to have a pinhole damage to the balloon.Analysis could not confirm the reported crossing difficulties, which could not be confirmed because the clinical circumstances could not be replicated.
 
Event or Problem Description
It was reported that balloon rupture occurred.The 95% stenosed target lesion was located in the severely tortuous and severely calcified left anterior descending artery.A 2.00mm x 20mm maverick balloon catheter was advanced for dilatation.However, during third inflation at 6 atmospheres, the balloon ruptured.The procedure was completed with another 2.00mm x 20mm maverick balloon catheter.There were no patient complications reported and the patient condition was good.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MAVERICK
Common Device Name
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
pmt 741 persiaran cassia selat
bandarcassia, pulau pinan 14110
MY   14110
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key17332832
Report Number2124215-2023-37397
Device Sequence Number17761620
Product Code LOX
UDI-Device Identifier08714729370161
UDI-Public08714729370161
Combination Product (Y/N)N
Initial Reporter CountryKS
PMA/510(K) Number
P860019
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 09/24/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date05/17/2026
Device Model Number7590
Device Catalogue Number7590
Device Lot Number0031641175
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 07/12/2023
Supplement Date Received by Manufacturer09/14/2023
Initial Report FDA Received Date07/17/2023
Supplement Report FDA Received Date09/24/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/18/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age80 YR
Patient SexMale
-
-